Integrated Filing — IndAS



General information about company
Scrip Code 544222
NSE Symbol AKUMS
MSEI Symbol NOTLISTED
ISIN INE09XN01023
Name of company Akums Drugs and Pharmaceuticals Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 26-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 19-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 26-May-2025   14:00:00
End date and time of board meeting 26-May-2025   16:42:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-26
Indicate Company website link for updated RPT policy of the Company https://www.akums.in/investors/corporate-governance-policies/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default on loan and debt securities as on 31.03.2025.



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 3287530000 13117840000
Other income 320500000 1241920000
Total income 3608030000 14359760000
2 Expenses
(a) Cost of materials consumed 2070630000 8110580000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 3490000 -100500000
(d) Employee benefit expense 538360000 2017360000
(e) Finance costs 26260000 153090000
(f) Depreciation, depletion and amortisation expense 100930000 395450000
(f) Other Expenses
1 Fair value changes to financial instrument 0 -38670000
2 Other Expenses 497810000 1744080000
Total other expenses 497810000 1705410000
Total expenses 3237480000 12281390000
3 Total profit before exceptional items and tax 370550000 2078370000
4 Exceptional items 0 0
5 Total profit before tax 370550000 2078370000
6 Tax expense
7 Current tax 82610000 496640000
8 Deferred tax 12050000 -28250000
9 Total tax expenses 94660000 468390000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 275890000 1609980000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 275890000 1609980000
17 Other comprehensive income net of taxes -580000 -720000
18 Total Comprehensive Income for the period 275310000 1609260000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 306210000 306210000
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.8 10.76
Diluted earnings (loss) per share from continuing operations 1.8 10.76
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.8 10.76
Diluted earnings (loss) per share from continuing and discontinued operations 1.8 10.76
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 3349170000
Capital work-in-progress 537110000
Investment property 184880000
Goodwill 0
Other intangible assets 26020000
Intangible assets under development 30240000
Biological assets other than bearer plants 0
Investments accounted for using equity method 3660140000
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 10443390000
Other non-current financial assets 100440000
Total non-current financial assets 10543830000
Deferred tax assets (net) 0
Other non-current assets 185900000
Total non-current assets 18517290000
2 Current assets
Inventories 2016890000
Current financial asset
Current investments 0
Trade receivables, current 2061370000
Cash and cash equivalents 764920000
Bank balance other than cash and cash equivalents 2796250000
Loans, current 0
Other current financial assets 204870000
Total current financial assets 5827410000
Current tax assets (net) 0
Other current assets 487510000
Total current assets 8331810000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 26849100000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 306210000
Other equity 22746260000
Total equity attributable to owners of parent 23052470000
Non controlling interest
Total equity 23052470000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 97840000
Total non-current financial liabilities 97840000
Provisions, non-current 129310000
Deferred tax liabilities (net) 74630000
Deferred government grants, Non-current 0
Other non-current liabilities 401770000
Total non-current liabilities 703550000
Current liabilities
Current financial liabilities
Borrowings, current 39300000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 225200000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1970350000
Total Trade payable 2195550000
Other current financial liabilities 705920000
Total current financial liabilities 2940770000
Other current liabilities 94780000
Provisions, current 57110000
Current tax liabilities (Net) 420000
Deferred government grants, Current 0
Total current liabilities 3093080000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 3796630000
Total equity and liabilites 26849100000
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block
Textual Information(1) Property, Plant and Equipment also includes Right of use asset of Rs. 702.12 million. nNon-Current Lease Liability of Rs. 401.77 million is shown in other non-current liabilities. n



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement gains/(losses) on defined benefit plans -770000 -960000
Total Amount of items that will not be reclassified to profit and loss -770000 -960000
2 Income tax relating to items that will not be reclassified to profit or loss -190000 -240000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -580000 -720000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2078370000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0
Adjustments for decrease (increase) in inventories -399860000
Adjustments for decrease (increase) in trade receivables, current 202560000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -87820000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 35750000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 583770000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 395450000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 91960000
Adjustments for provisions, non-current 20000000
Adjustments for other financial liabilities, current -400590000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 973110000
Adjustments for share-based payments 15600000
Adjustments for fair value losses (gains) -38670000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) -37360000
Other adjustments for non-cash items -34790000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships -85890000
Total adjustments for reconcile profit (loss) -713000000
Net cash flows from (used in) operations 1365370000
Dividends received 0
Interest paid -153090000
Interest received 0
Income taxes paid (refund) 507940000
Other inflows (outflows) of cash -100500000
Net cash flows from (used in) operating activities 910020000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 2270900000
Other cash receipts from sales of equity or debt instruments of other entities -2750870000
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 935960000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 16556010000
Cash receipts from repayment of advances and loans made to other parties 16829300000
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 973110000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 122900000
Net cash flows from (used in) investing activities -4588430000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 6373700000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 2223560000
Payments of lease liabilities 274300000
Dividends paid 0
Interest paid 122080000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 3753760000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 75350000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 75350000
Cash and cash equivalents cash flow statement at beginning of period 689570000
Cash and cash equivalents cash flow statement at end of period 764920000





Details of Impact of Audit Qualification
Whether results are audited or unaudited
Declaration of unmodified opinion or statement on impact of audit qualification
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Loan 1315000000 Approved 626300000 2055000000 2651000000 Loan 0.0825 upto december 2026 Unsecured Business Purpose
2 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Loan 177000000 Approved 30000000 0 0
3 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Interest received 162870000 Approved 95750000 12040000 16270000
4 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 3160000 Approved 790000 0 0
5 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Sale of goods or services 100000000 Approved 15570000 440000 1460000
6 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Sale of fixed assets 3410000 Approved 970000 0 0
7 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Purchase of goods or services 200000000 Approved 12380000 50000 13910000
8 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Purchase of fixed assets 5430000 Approved 4560000 0 0
9 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 5730000 Approved 1620000 0 0
10 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Corporate guarantee withdrawn 177000000 Approved 74360000 0 0
11 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Loan 7276680000 Approved 1548300000 1648100000 1727700000 Loan 0.0825 upto December 2026 Unsecured Business Purpose
12 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Loan 3976880000 Approved 1468700000 0 0
13 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Interest received 144410000 Approved 66820000 9490000 9930000
14 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 9070000 Approved 3700000 0 0
15 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Received 19820000 Approved 9260000 0 0
16 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 200000000 Approved 80210000 2000000 29910000
17 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses incurred 1000000 Approved 0 0 0
18 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Charges 81870000 Approved 44010000 0 0
19 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Sales of RODTEP scrips 0 Approved 1160000 0 0
20 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services 581300000 Approved 155310000 24420000 43460000
21 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Purchase of fixed assets 6000000 Approved 680000 0 0
22 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Sale of fixed assets 4190000 Approved 320000 0 0
23 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company 2000000 Approved 70000 0 0
24 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Loan 7967500000 Approved 821400000 3000000 0 Loan 0.0825 upto december 2026 Unsecured Business Purpose
25 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Loan 7191130000 Approved 824400000 824400000 0
26 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Interest received 88700000 Approved 3300000 140000 470000
27 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 4940000 Approved 1980000 0 0
28 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 6880000 Approved 2780000 0 0
29 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Expenses incurred 1000000 Approved 60000 0 0
30 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Consumption of stores and spare parts 5000000 Approved 2860000 0 0
31 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Sale of goods or services 150000000 Approved 4430000 -140000 2040000
32 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company 2000000 Approved 20000 0 0
33 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Purchase of goods or services 1729990000 Approved 589570000 74150000 194000000
34 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Purchase of fixed assets 1000000 Approved 310000 0 0
35 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Sale of fixed assets 3330000 Approved 1050000 0 0
36 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Investment 250000000 Approved 250000000 0 0
37 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Loan 100000000 Approved 0 63500000 0 Loan 0.0825 upto December 2026 Unsecured Business Purpose
38 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Loan 30000000 Approved 63500000 63500000 0
39 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Interest received 25710000 Approved 940000 380000 0
40 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 2500000 Approved 590000 0 0
41 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Sale of goods or services 100000000 Approved 11590000 9220000 13210000
42 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Sale of goods or services 5020000 Approved 10000 0 0
43 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Purchase of goods or services 0 Approved -20000 150000 0
44 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 6000000 Approved 1350000 0 0
45 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Corporate guarantee withdrawn 15000000 Approved 80000 0 0
46 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Rent Received 5710000 Approved 560000 0 0
47 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Purchase of fixed assets 1000000 Approved 20000 0 0
48 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Loan 420250000 Approved 0 373250000 0 Loan 0.0825 Upto December 2026 Unsecured Business Purpose
49 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Loan 130550000 Approved 373250000 0 0
50 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Interest received 29840000 Approved 5500000 2210000 0
51 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 12210000 Approved 2240000 0 0
52 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 2500000 Approved 420000 0 0
53 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Interest received 2090000 Approved 730000 0 0
54 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Sale of goods or services 297980000 Approved 41340000 66980000 22170000
55 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Sale of goods or services 1730000 Approved 10000 0 0
56 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Corporate guarantee withdrawn 65280000 Approved 34580000 0 0
57 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Security deposit received 0 Approved 0 0 780000
58 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Loan 12854300000 Approved 2562000000 5032700000 5315800000 Loan 0.0825 Upto December 2026 Unsecured Business Purpose
59 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Loan 10169500000 Approved 2278900000 0 0
60 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Interest received 476700000 Approved 230160000 28570000 33390000
61 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 22410000 Approved 10480000 0 0
62 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Received 17580000 Approved 8370000 0 0
63 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 408970000 Approved 183360000 8950000 53020000
64 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Sale of fixed assets 54790000 Approved 6120000 0 0
65 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company 9000000 Approved 780000 0 0
66 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Charges 274290000 Approved 118230000 0 0
67 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services 1094980000 Approved 239770000 29740000 19140000
68 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Consumption of stores and spare parts 10000000 Approved 3210000 0 0
69 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Purchase of fixed assets 62940000 Approved 2740000 0 0
70 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Income 19140000 Approved 10610000 0 0
71 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Investment 2020900000 Approved 2020900000 0 0
72 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Loan 587500000 Approved 0 500000000 0 Loan 0.0825 upto December 2026 Unsecured Business Purpose
73 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Loan 700000000 Approved 500000000 0 0
74 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Interest received 50780000 Approved 6740000 2960000 0
75 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 3310000 Approved 540000 0 0
76 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company 2000000 Approved 980000 0 0
77 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Job Work Income 7500000 Approved 10000 0 0
78 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Sale of goods or services 1169010000 Approved 422830000 227330000 304870000
79 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Sale of goods or services 13420000 Approved 6650000 0 0
80 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 9700000 Approved 2490000 0 0
81 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Loan 0 Approved 0 144900000 138900000 Loan 0.0825 upto December 2026 Unsecured Business Purpose
82 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Loan 209000000 Approved 6000000 0 0
83 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Interest received 13980000 Approved 5860000 860000 1700000
84 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 2500000 Approved 260000 0 0
85 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Sale of goods or services 50000000 Approved 1970000 390000 1990000
86 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Sale of fixed assets 4000000 Approved 80000 0 0
87 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Any other transaction Consumption of stores and spare parts 164450000 Approved 23280000 0 0
88 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Purchase of goods or services 70860000 Approved 20870000 22770000 8270000
89 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Purchase of fixed assets 2240000 Approved 160000 0 0
90 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Any other transaction Repairs and maintenance- Plant and machinery 49910000 Approved 5640000 0 0
91 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Sale of goods or services 10000 Approved 0 0 0
92 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Any other transaction Job Work Charges 10000000 Approved 820000 0 0
93 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Wholly owned subsidiary Any other transaction Share of profit from Partnership firm/ LLP 100000000 Approved 23920000 0 123860000
94 Akums Drugs and Pharmaceuticals Ltd. May and Baker Pharmacuticals Ltd. Entity in which relatives of KMP are interested Sale of goods or services 50000000 Approved 7750000 13570000 260000
95 Akums Drugs and Pharmaceuticals Ltd. May and Baker Pharmacuticals Ltd. Entity in which relatives of KMP are interested Any other transaction Expenses paid by other Group Company 2000000 Approved 210000 150000 190000
96 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Loan 567000000 Approved 0 312700000 0 Loan 0.0825 Upto December 2026 Unsecured Business Purpose
97 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Loan 100000000 Approved 312700000 0 0
98 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Interest received 28120000 Approved 4910000 1890000 0
99 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 100000000 Approved 4520000 2430000 3700000
100 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 2500000 Approved 440000 0 0
101 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 5060000 Approved 0 0 0
102 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Received 9000000 Approved 2520000 0 0
103 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 2500000 Approved 350000 0 0
104 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Security deposit received 0 Approved 0 0 2690000
105 Akums Drugs and Pharmaceuticals Ltd. Akumentis Healthcare Limited Subsidiary Any other transaction Expense incurred on behalf of Company 2500000 Approved 220000 0 0
106 Akums Drugs and Pharmaceuticals Ltd. Akumentis Healthcare Limited Subsidiary Sale of goods or services 354930000 Approved 115800000 52220000 28540000
107 Akums Drugs and Pharmaceuticals Ltd. Akumentis Healthcare Limited Subsidiary Sale of goods or services 7240000 Approved 340000 0 0
108 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Loan 850000000 Approved 60870000 483640000 544510000 Loan 0.0825 upto December 2026 Unsecured Business Purpose
109 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 50000000 Approved 10000 30000 0
110 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services 25570000 Approved 4390000 970000 1320000
111 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 10200000 Approved 60000 0 0
112 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Interest received 27920000 Approved 21480000 2870000 3420000
113 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Paid 5000000 Approved 1830000 0 0
114 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company 2000000 Approved 30000 0 0
115 Akums Drugs and Pharmaceuticals Ltd. Akums Health and Education Society Entity in which KMP are interested Sale of goods or services 10000000 Approved 10000 10000 10000
116 Akums Drugs and Pharmaceuticals Ltd. Akums Foundation Entity in which KMP are interested Sale of goods or services 10000000 Approved 10000 0 10000
117 Akums Drugs and Pharmaceuticals Ltd. Akums Foundation Entity in which KMP are interested Any other transaction CSR Contribution 100000000 Approved 4100000 0 0
118 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt Ltd Entity in which KMP are interested Any other transaction Rent Paid 30050000 Approved 12960000 0 1840000
119 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt Ltd Entity in which KMP are interested Any other transaction Expenses incurred on behalf of the Company 1000000 Approved 110000 70000 180000
120 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt Ltd Entity in which KMP are interested Purchase of goods or services 32990000 Approved 13990000 5350000 3450000
121 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt Ltd Entity in which KMP are interested Any other transaction Expenses paid by other Group Company 12000000 Approved 2540000 0 0
122 Akums Drugs and Pharmaceuticals Ltd. AVHA Lifesciences Pvt Ltd Entity in which KMP are interested Any other transaction Expenses paid by other Group Company 1000000 Approved 100000 0 0
123 Akums Drugs and Pharmaceuticals Ltd. Akums Employee Benefit Trust Subsidiary Loan 3004350000 Approved 0 3004350000 3004350000
124 Akums Drugs and Pharmaceuticals Ltd. Sanjeev Jain Managing Director Remuneration Approved 52480000 3000000 13800000
125 Akums Drugs and Pharmaceuticals Ltd. Sanjeev Jain Managing Director Any other transaction Rent Paid Approved 2070000 0 0
126 Akums Drugs and Pharmaceuticals Ltd. Sandeep Jain Managing Director Remuneration Approved 51570000 3000000 14200000
127 Akums Drugs and Pharmaceuticals Ltd. Sandeep Jain Managing Director Any other transaction Rent Paid Approved 2550000 0 0
128 Akums Drugs and Pharmaceuticals Ltd. Kewal Handa Independent Director Any other transaction Legal and Professional charges Approved 1700000 0 0
129 Akums Drugs and Pharmaceuticals Ltd. Matangi Gowrishankar Independent Director Any other transaction Legal and Professional charges Approved 1200000 0 0
130 Akums Drugs and Pharmaceuticals Ltd. Nand Lal Kalra Independent Director Any other transaction Expenses incurred Approved 10000 0 0
131 Akums Drugs and Pharmaceuticals Ltd. Arushi Jain Relative of KMP Remuneration Approved 3820000 450000 440000
132 Akums Drugs and Pharmaceuticals Ltd. Umang Jain Relative of KMP Remuneration Approved 1200000 170000 170000
133 Akums Drugs and Pharmaceuticals Ltd. Shivangi Jain Relative of KMP Remuneration Approved 1200000 170000 150000
134 Malik Lifesciences Pvt Ltd Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution Approved 1210000 0 0
135 Malik Lifesciences Pvt Ltd Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 2060000 30000 1170000
136 Malik Lifesciences Pvt Ltd Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Sale of fixed assets Approved 1210000 0 0
137 Malik Lifesciences Pvt Ltd Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 0 0 0
138 Malik Lifesciences Pvt Ltd Akumentis Healthcare Limited Fellow Subsidiary Sale of goods or services Approved 45300000 24650000 19850000
139 Malik Lifesciences Pvt Ltd Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 2310000 450000 1470000
140 Malik Lifesciences Pvt Ltd Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of fixed assets Approved 50000 0 0
141 Malik Lifesciences Pvt Ltd Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 43850000 560000 310000
142 Malik Lifesciences Pvt Ltd Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 0 0 0
143 Malik Lifesciences Pvt Ltd Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 21780000 22390000 24250000
144 Malik Lifesciences Pvt Ltd Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Approved 4950000 3780000 4470000
145 Malik Lifesciences Pvt Ltd Plenteous Pharmaceuticals ltd Fellow Subsidiary Any other transaction Service Income Approved 20000 0 0
146 Malik Lifesciences Pvt Ltd Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Approved 79650000 38960000 60240000
147 Malik Lifesciences Pvt Ltd Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Approved 20000 0 0
148 Malik Lifesciences Pvt Ltd Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 13530000 6110000 3590000
149 Malik Lifesciences Pvt Ltd Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 1200000 1140000 840000
150 Malik Lifesciences Pvt Ltd Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses incurred on behalf of the Company Approved 3010000 0 0
151 Malik Lifesciences Pvt Ltd Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid Approved 6630000 0 0
152 Akums Healthcare Ltd. Akome Lifecare Pvt. Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 50000 0 0
153 Akums Healthcare Ltd. Akome Lifecare Pvt Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expense incurred on behalf of Company Approved 3010000 0 0
154 Akums Healthcare Ltd. Akumentis Healthcare Limited Fellow Subsidiary Sale of goods or services Approved 4020000 0 0
155 Akums Healthcare Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 14970000 1630000 10260000
156 Akums Healthcare Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of fixed assets Approved 30000 0 0
157 Akums Healthcare Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 0 390000 0
158 Akums Healthcare Ltd. Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Sale of fixed assets Approved 1630000 0 0
159 Akums Healthcare Ltd. Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 2990000 50000 610000
160 Akums Healthcare Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 150000 0 0
161 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 30000 0 40000
162 Akums Healthcare Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 0 110000 0
163 Akumentis Healtcare Ltd Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Royalty Income Approved 2090000 580000 1150000
164 Akumentis Healtcare Ltd Medibox Pharma Pvt. Ltd. Fellow Subsidiary Interest received Approved 7260000 0 1810000
165 Akumentis Healtcare Ltd Nicholas Healthcare Ltd. Fellow Subsidiary Interest received Approved 1590000 0 350000
166 Akumentis Healtcare Ltd Unosource Pharma Ltd. Fellow Subsidiary Interest received Approved 11800000 0 2840000
167 Akumentis Healtcare Ltd Medibox Pharma Pvt. Ltd. Fellow Subsidiary Loan 400000000 Approved 299700000 0 285700000
168 Akumentis Healtcare Ltd Nicholas Healthcare Ltd. Fellow Subsidiary Loan 200000000 Approved 66000000 0 55500000
169 Akumentis Healtcare Ltd Unosource Pharma Ltd. Fellow Subsidiary Loan 900000000 Approved 450000000 0 450000000
170 Akumentis Healtcare Ltd Plenteous Pharmaceuticals Ltd Fellow Subsidiary Interest received 0 Approved 10960000 0 0
171 Akumentis Healtcare Ltd Plenteous Pharmaceuticals Ltd Fellow Subsidiary Loan 0 Approved 4110000 0 0
172 Akumentis Healtcare Ltd Plenteous Pharmaceuticals Ltd Fellow Subsidiary Loan 600000000 Approved 420030000 0 415930000
173 Akumentis Healtcare Ltd Medibox Pharma Pvt. Ltd. Fellow Subsidiary Loan 0 Approved 14000000 0 0
174 Akumentis Healtcare Ltd Nicholas Healthcare Ltd. Fellow Subsidiary Loan 0 Approved 10500000 0 0
175 Akumentis Healtcare Ltd Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution Approved 4000000 0 0
176 Akumentis Healtcare Ltd Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 10000 20000 0
177 Maxcure Nutravedics Ltd Akums Healthcare Ltd. Fellow Subsidiary Sale of fixed assets Approved 0 0 0
178 Maxcure Nutravedics Ltd Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution Approved 2000000 0 0
179 Maxcure Nutravedics Ltd Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of fixed assets Approved 0 0 0
180 Maxcure Nutravedics Ltd May and Baker Pharmacuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 1230000 0 0
181 Maxcure Nutravedics Ltd Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company Approved 510000 0 0
182 Maxcure Nutravedics Ltd Akome Lifecare Pvt. Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 1780000 1180000 280000
183 Maxcure Nutravedics Ltd Akome Lifecare Pvt. Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid Approved 2200000 0 0
184 Maxcure Nutravedics Ltd Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 34480000 110000 1170000
185 Maxcure Nutravedics Ltd Akumentis Healthcare Limited Fellow Subsidiary Sale of goods or services Approved 16510000 10030000 6250000
186 Maxcure Nutravedics Ltd Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 632860000 5630000 203940000
187 Maxcure Nutravedics Ltd Medibox Pharma Pvt. Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0 0 0
188 Maxcure Nutravedics Ltd Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Sale of fixed assets Approved 1380000 0 0
189 Maxcure Nutravedics Ltd Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 618320000 88360000 188340000
190 Maxcure Nutravedics Ltd Upadhrish Reserchem LLP Fellow Subsidiary Sale of fixed assets Approved 50000 0 0
191 Maxcure Nutravedics Ltd Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 13480000 2210000 7070000
192 Maxcure Nutravedics Ltd Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 0 1180000 10000
193 Maxcure Nutravedics Ltd Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Approved 2500000 2780000 1300000
194 Maxcure Nutravedics Ltd Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0 0 0
195 Maxcure Nutravedics Ltd Plenteous Pharmaceuticals Ltd Fellow Subsidiary Sale of goods or services Approved 0 90000 0
196 Maxcure Nutravedics Ltd Plenteous Pharmaceuticals Ltd Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0 0 0
197 Medibox Pharma Pvt. Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 60000 0 0
198 Medibox Pharma Pvt. Ltd. May and Baker Pharmacuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 0 0 20000
199 Medibox Pharma Pvt. Ltd. May and Baker Pharmacuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company Approved 160000 0 0
200 Medibox Pharma Pvt. Ltd. May and Baker Pharmacuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses incurred on behalf of the Company Approved 30000 0 0
201 Medibox Pharma Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 30000 0 0
202 Medibox Pharma Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 120000 0 0
203 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company Approved 3070000 0 0
204 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt.Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 9860000 3600000 1910000
205 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt.Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid Approved 13240000 0 0
206 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 80000 0 0
207 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of fixed assets Approved 230000 0 0
208 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 1720000 90000 120000
209 Pure & Cure Healthcare Pvt. Ltd. Akumentis Healthcare Limited Fellow Subsidiary Sale of goods or services Approved 183750000 52840000 58040000
210 Pure & Cure Healthcare Pvt. Ltd. Akumentis Healthcare Limited Fellow Subsidiary Any other transaction Service Income Approved 250000 0 0
211 Pure & Cure Healthcare Pvt. Ltd. May and Baker Pharmacuticals Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 6970000 1950000 0
212 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 10000 0 0
213 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of fixed assets Approved 150000 0 0
214 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 92240000 7350000 7700000
215 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of fixed assets Approved 530000 0 0
216 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 1450000 390000 150000
217 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 18740000 3510000 7050000
218 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of fixed assets Approved 80000 0 0
219 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 830000 290000 260000
220 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Expenses incured on behalf of the Company Approved 20000 0 0
221 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 59880000 68440000 36430000
222 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 140000 0 0
223 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 30000 40000 0
224 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 5500000 0 0
225 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Approved 9580000 8420000 10950000
226 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Approved 200000 0 0
227 Pure & Cure Healthcare Pvt. Ltd. Akums Health and Education Society Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of fixed assets Approved 200000 10000 240000
228 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Approved 15660000 27030000 12600000
229 Pure & Cure Healthcare Pvt. Ltd. Sarvagunaushdhi Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 0 109650000 100720000
230 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Service Income Approved 30000 0 0
231 Upadhrish Reserchem LLP Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 0 0 0
232 Upadhrish Reserchem LLP Akome Lifecare Pvt Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 0 0 0
233 Upadhrish Reserchem LLP Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 80000 830000 900000
234 Upadhrish Reserchem LLP Akums Healthcare Ltd. Fellow Subsidiary Sale of fixed assets Approved 2040000 0 0
235 Upadhrish Reserchem LLP Akums Healthcare Ltd. Fellow Subsidiary Any other transaction Service Income Approved 4920000 0 0
236 Upadhrish Reserchem LLP Akumentis Healthcare Limited Fellow Subsidiary Any other transaction Service Income Approved 2390000 1580000 80000
237 Upadhrish Reserchem LLP Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 2590000 9230000 1510000
238 Upadhrish Reserchem LLP Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Any other transaction Service Income Approved 6040000 0 0
239 Upadhrish Reserchem LLP Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 8290000 3760000 2520000
240 Upadhrish Reserchem LLP Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Service Income Approved 8790000 0 0
241 Upadhrish Reserchem LLP Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 41490000 11190000 14130000
242 Upadhrish Reserchem LLP Pure & Cure Healthcare Pvt. Ltd. Fellow Subsidiary Any other transaction Service Income Approved 35860000 0 0
243 Upadhrish Reserchem LLP Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0 0 0
244 Nicholas Healthcare Ltd Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 11190000 0 0
245 Nicholas Healthcare Ltd Akumentis Healthcare Limited Fellow Subsidiary Sale of goods or services Approved 30560000 0 8000000
246 Nicholas Healthcare Ltd Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 10000 0 10000
247 Nicholas Healthcare Ltd Medibox Pharma Pvt. Ltd. Fellow Subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 340000 0 0
248 Nicholas Healthcare Ltd Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Rent Received Approved 330000 0 0
249 Nicholas Healthcare Ltd Plenteous Pharmaceuticals Ltd Fellow Subsidiary Sale of fixed assets Approved 0 0 360000
250 Plenteous Pharmaceuticals Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 50000 0 0
251 Plenteous Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 40000 0 0
252 Plenteous Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of fixed assets Approved 10000 0 0
253 Plenteous Pharmaceuticals Ltd. Welcure Pharma (P) Ltd Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Royalty Expense Approved -60000 0 0
254 Plenteous Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 0 40000 0
255 Qualymed Pharma Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsdiary Any other transaction Expenses incurred on behalf of the Company Approved 0 0 0
256 Qualymed Pharma Pvt. Ltd. Akums Healhcare Ltd Fellow Subsdiary Sale of goods or services Approved 410000 30000 30000
257 Qualymed Pharma Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsdiary Sale of goods or services Approved 270000 0 0
258 Qualymed Pharma Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsdiary Sale of goods or services Approved 80000 0 0
259 Qualymed Pharma Pvt. Ltd. Pure & Cure Healthcare Pvt. Ltd. Fellow Subsdiary Sale of goods or services Approved 7970000 2430000 710000
260 Unosource Pharma Ltd. Akumentis Healthcare Limited Fellow subsidiary Any other transaction Expenses incurred on behalf of the Company Approved 10000 0 0
261 Unosource Pharma Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution Approved 1960000 0 0
262 Unosource Pharma Ltd. Malik Lifesciences Pvt. Ltd. Fellow subsidiary Any other transaction Sale of MEIS Approved 2550000 0 0
263 Unosource Pharma Ltd. Maxcure Nutravedics Ltd. Fellow subsidiary Any other transaction Sale of MEIS Approved 620000 0 0
264 Pure & Cure Healthcare Pvt. Ltd. Lata Jain Relative of KMP of holding company Remuneration Approved 2840000 310000 290000
265 Maxcure Nutravedics Ltd. Archana Jain Relative of KMP of holding company Remuneration Approved 2730000 310000 310000
266 Akumentis Healthcare Limited Kanishk Jain Director in subsidiary Remuneration Approved 3870000 370000 500000
267 Akumentis Healthcare Limited Sanjeev Jain KMP of Holding Company Any other transaction Rent Paid Approved 3550000 0 0
268 Akumentis Healthcare Limited Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 3550000 0 0
269 Akumentis Healthcare Limited Lata Jain Relative of KMP of holding company Any other transaction Rent Paid Approved 60000 0 0
270 Akumentis Healthcare Limited Sanjeev Jain KMP of Holding Company Any other transaction Security Deposit given Approved 0 5000000 5000000
271 Akumentis Healthcare Limited Sandeep Jain KMP of Holding Company Any other transaction Security Deposit given Approved 0 5000000 5000000
272 Medibox Pharma Pvt. Ltd. Sanjeev Jain KMP of Holding Company Any other transaction Rent Paid Approved 210000 0 0
273 Medibox Pharma Pvt. Ltd. Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 510000 0 0
274 Medibox Pharma Pvt. Ltd. Arushi Jain Relative of KMP of holding company Any other transaction Director Sitting fees Approved 10000 0 0
275 Unosource Pharma Ltd. Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 6820000 0 0
276 Unosource Pharma Ltd. Sanjeev Jain KMP of Holding Company Any other transaction Rent Paid Approved 6820000 0 0
277 Upadhrish Reserchem LLP Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 70000 0 0
278 Plenteous Pharmaceuticals Ltd. Sanjeev Jain KMP of Holding Company Any other transaction Rent Paid Approved 600000 0 0
279 Plenteous Pharmaceuticals Ltd. Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 60000 0 0
280 Malik Lifesciences Pvt. Ltd. Archana Jain Relative of KMP of holding company Any other transaction Rent Paid Approved 340000 0 0
281 Malik Lifesciences Pvt.Ltd Sandeep Jain KMP of holding company Any other transaction Rent Paid Approved 60000 0 0
282 Maxcure Nutravedics Ltd. Lata Jain Relative of KMP of holding company Any other transaction Rent Paid Approved 170000 0 0
283 Maxcure Nutravedics Ltd Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 180000 0 0
284 Maxcure Nutravedics Ltd Sanjeev Jain KMP of Holding Company Any other transaction Rent Paid Approved 30000 0 0
285 Pure & Cure Healthcare Pvt. Ltd. Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 1020000 0 0
286 Pure & Cure Healthcare Pvt. Ltd. Sanjeev Jain KMP of Holding Company Any other transaction Rent Paid Approved 960000 0 0
287 Qualymed Pharma Pvt. Ltd. Sandeep Jain KMP of Holding Company Any other transaction Rent Paid Approved 30000 0 0
Total value of transaction during the reporting period 20185640000